Literature DB >> 27063276

Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.

Kristina R Chacko1, John Reinus2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver disease that is often associated with the metabolic syndrome. There is a growing awareness that extrahepatic complications occur in individuals with NAFLD, especially an increased risk of cardiovascular disease. Development of diabetes mellitus, chronic kidney disease, colorectal cancer, and endocrinopathies has been linked to NAFLD. This article reviews the extrahepatic complications affecting individuals with NAFLD and the pathogenesis underlying their development.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Extrahepatic complications; Metabolic syndrome; Nonalcoholic fatty liver disease (NAFLD)

Mesh:

Year:  2016        PMID: 27063276     DOI: 10.1016/j.cld.2015.10.004

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  16 in total

1.  Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.

Authors:  Thomas Ebert; Nicolas Linder; Alexander Schaudinn; Harald Busse; Joachim Berger; Ralf Lichtinghagen; Volker Keim; Johannes Wiegand; Thomas Karlas
Journal:  Endocrine       Date:  2017-09-15       Impact factor: 3.633

2.  The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population.

Authors:  Xiuying Zhang; Xianghai Zhou; Xueyao Han; Zuodi Fu; Lianying Wang; Yufeng Li; Linong Ji
Journal:  Metab Syndr Relat Disord       Date:  2020-05-27       Impact factor: 1.894

3.  Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship.

Authors:  Balazs I Bodai; Therese E Nakata
Journal:  Perm J       Date:  2020

4.  Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.

Authors:  Zhiwei Zhou; Kai Song; Jing Qiu; Yiying Wang; Chunxing Liu; Hui Zhou; Yunfang Xu; Zhirong Guo; Biao Zhang; Chen Dong
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

Review 5.  Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets.

Authors:  Ya-Hui Ding; Yuan Ma; Lin-Yan Qian; Qiang Xu; Li-Hong Wang; Dong-Sheng Huang; Hai Zou
Journal:  Oncotarget       Date:  2017-07-24

6.  Fatty Liver as a Potential Surrogate for Waist Circumference in the Diagnosis of Metabolic Syndrome: A Population-Based Study among Chinese Adults.

Authors:  Boren Jiang; Ting Gu; Kun Zhou; Yanjun Zheng; Yuyu Guo; Yingli Lu
Journal:  Int J Endocrinol       Date:  2018-04-10       Impact factor: 3.257

7.  Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency.

Authors:  Ga Eun Nam; Soon Young Hwang; Hye Soo Chung; Ju Hee Choi; Hyun Jung Lee; Nam Hoon Kim; Hye Jin Yoo; Ji-A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Kyung Mook Choi
Journal:  Int J Endocrinol       Date:  2018-04-02       Impact factor: 3.257

8.  Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis.

Authors:  Shou-Sheng Liu; Xue-Feng Ma; Jie Zhao; Shui-Xian Du; Jie Zhang; Meng-Zhen Dong; Yong-Ning Xin
Journal:  Lipids Health Dis       Date:  2020-05-31       Impact factor: 3.876

Review 9.  Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Xiaoyan Li; Hua Wang
Journal:  Cell Biosci       Date:  2020-12-07       Impact factor: 7.133

10.  Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Authors:  Lei Xiu; Tao Jiang; Xiao-Ai Yao; Zhen Wen
Journal:  Int J Gen Med       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.